Compugroup Total Revenue from 2010 to 2026
| COP Stock | EUR 27.10 0.10 0.37% |
Total Revenue | First Reported 2019-03-31 | Previous Quarter 308.7 M | Current Value 286.2 M | Quarterly Volatility 46.8 M |
Check Compugroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compugroup Medical's main balance sheet or income statement drivers, such as Tax Provision of 26 M, Interest Income of 1.2 M or Interest Expense of 40.3 M, as well as many indicators such as . Compugroup financial statements analysis is a perfect complement when working with Compugroup Medical Valuation or Volatility modules.
Compugroup | Total Revenue |
Evaluating Compugroup Medical's Total Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Compugroup Medical SE's fundamental strength.
Latest Compugroup Medical's Total Revenue Growth Pattern
Below is the plot of the Total Revenue of Compugroup Medical SE over the last few years. Total revenue comprises all receipts Compugroup Medical generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Compugroup Medical's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Compugroup Medical's overall financial position and show how it may be relating to other accounts over time.
| Total Revenue | 10 Years Trend |
|
Total Revenue |
| Timeline |
Compugroup Total Revenue Regression Statistics
| Arithmetic Mean | 799,881,977 | |
| Geometric Mean | 759,108,430 | |
| Coefficient Of Variation | 34.28 | |
| Mean Deviation | 239,088,091 | |
| Median | 717,023,000 | |
| Standard Deviation | 274,208,705 | |
| Sample Variance | 75190.4T | |
| Range | 766.9M | |
| R-Value | 0.89 | |
| Mean Square Error | 16526.6T | |
| R-Squared | 0.79 | |
| Slope | 48,384,365 | |
| Total Sum of Squares | 1203046.6T |
Compugroup Total Revenue History
About Compugroup Medical Financial Statements
Compugroup Medical investors utilize fundamental indicators, such as Total Revenue, to predict how Compugroup Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 1.3 B | 970.4 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.